BriaCell Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:8BT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Dec 24	Buy€39,347	Marc Lustig	Individual	37,500	€1.05
17 May 24	Buy€1,843,754	Marc Lustig	Individual	902,935	€2.04
14 May 24	Buy€1,848,801	Marc Lustig	Individual	902,935	€2.05

Insider Trading Volume

Insider Buying: 8BT insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 8BT?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	818,375	1.85%
Institutions	1,055,607	2.39%
Individual Insiders	6,826,964	15.4%
General Public	35,503,215	80.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 176.6%.

Top Shareholders

Top 25 shareholders own 19.68% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.7%	Marc Lustig	6,501,805	€2.8m	156%	no data
1.85%	Copia Fund (Cayman) LP	818,375	€358.5k	0%	no data
1.36%	Heights Capital Management, Inc.	600,000	€262.9k	0%	0.05%
0.37%	Jamieson Bondarenko	161,523	€70.8k	34.8%	no data
0.32%	William Williams	142,969	€62.6k	-4.46%	no data
0.18%	Vontobel Asset Management, Inc.	80,000	€35.0k	0%	no data
0.17%	Hudson River Trading LLC, Asset Management Arm	74,286	€32.5k	0%	no data
0.11%	Onyx Bridge Wealth Group LLC	50,000	€21.9k	0%	no data
0.086%	Group One Trading LP, Asset Management Arm	37,885	€16.6k	248%	no data
0.08%	BMO Asset Management Corp.	35,330	€15.5k	-37.3%	no data
0.079%	Summit Trail Advisors, LLC	35,000	€15.3k	0%	no data
0.068%	LPL Financial Corporation, Asset Management Arm	30,259	€13.3k	162%	no data
0.06%	XTX Holdings Limited, Asset Management Arm	26,422	€11.6k	114%	no data
0.04%	Vaughn Embro-Pantalony	17,857	€7.8k	87.5%	no data
0.037%	Cambridge Investment Research Advisors, Inc.	16,300	€7.1k	0%	no data
0.033%	HighTower Advisors, LLC	14,628	€6.4k	-0.68%	no data
0.032%	Concord Wealth Partners	14,076	€6.2k	36.7%	no data
0.031%	Susquehanna International Group, LLP, Asset Management Arm	13,899	€6.1k	12.5%	no data
0.018%	National Bank Investments Inc.	7,788	€3.4k	3.84%	no data
0.016%	Geode Capital Management, LLC	6,991	€3.1k	-5.9%	no data
0.0086%	RBC Dominion Securities Inc., Asset Management Arm	3,813	€1.7k	-0.5%	no data
0.0065%	Toronto-Dominion Bank, Banking Investments	2,850	€1.2k	-17.4%	no data
0.0064%	Gadi Levin	2,810	€1.2k	0%	no data
0.006%	Morgan Stanley, Investment Banking and Brokerage Investments	2,658	€1.2k	0%	no data
0.0023%	Osaic Wealth, Inc. , Asset Management Arm	1,000	€437.7	-2.53%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/08 01:08
End of Day Share Price	2025/01/08 00:00
Earnings	2024/10/31
Annual Earnings	2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BriaCell Therapeutics Corp. is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Emily Bodnar	H.C. Wainwright & Co.
Ashok Kumar	ThinkEquity LLC